MarkWide Research

Sale!

Contrast Media Injectors Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: July, 2022
No of Pages: 172
Delivery Format: PDF + Excel

$2,950.00

Report Description

The global market for contrast media injectors size was estimated at $1,405.90 million by 2020 and is projected to rise to $2,608.20 million in 2030, growing at an average rate of 8.00 per cent from 2021 until 2030.

Contrast media injectors can be designed to manage contrast materials ahead of diagnostic imaging procedures, for example, CT and MRI scans, which can improve the image’s quality. Contrast injectors come with features like preset protocols and security measures to stop the spread of contrast media by doctors. Counter media injectors could reduce the chance of adverse outcomes, for instance, the development of air emboli that is resulted from improper contrast injection of the material. Since they limit the volume of the contrast, they also increase the intensity between the injectors can be significantly raised.

The COVID-19 pandemic is a severe global impact on the health of people and also has a significant economic impact on a majority of nations. The epidemic has placed enormous pressure on health care systems. This time, healthcare institutions and providers have been instructed to stay clear of elective surgical procedures or medical examinations to reduce the spread risk and preserve the resources needed for patients with COVID-19. Several radiology departments have experienced an increase in patient numbers. The location of practice and the extent of the COVID-19 pandemic within each region Radiology departments should anticipate a 50%-70 per cent decrease in imaging volumes which will last for at least 3-4 months. The future is likely to be uncertain because of COVID-19. The demand for contrast injections will be determined by the volume of diagnostic imaging and the amount of CT and MRI installations. We can expect the demand for diagnostic imaging to increase in the next few months, which could also increase the demand for contrast injections.

Factors like the growing rate of both cancers and CVD, many approvals for contrast agents, increased investment grants, and funding from government institutions drive the market for contrast media injector growth. However, the cost of contrast media injectors, accessories, and consumables limits the market’s expansion to a certain degree.

Contrast Media Injectors Market Segmentation

The market for contrast media injectors is classified according to the type of product applications, end-users, and geographic region. Based on the product type, the market is classified into injector systems, consumables and accessories. In terms of application, it is broken down into interventional cardiology, radiology or interventional radiology. The end-user is separated into hospitals and ambulatory surgical and diagnostic imaging centres.

Consumables hold the leading position through 2020 and will remain in the lead in the coming time.

The market for contrast media injectors is studied throughout North America (the U.S., Canada, and Mexico), Europe (Germany, France and Europe (Germany, France, UK, Italy, Spain and the rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and the rest of LAMEA).

Contrast Media Injectors Market  Report Scope and Segmentation 
 
ATTRIBUTESDETAILS
ESTIMATED YEAR2022
BASE YEAR2021
FORECAST YEAR2030
HISTORICAL YEAR2017-2021
UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

 

Radiology is predicted to be one of the highest-paying segments.

Segment review

Based on the product type, the consumables market is predicted to have the highest growth rate over the forecast time. The rapid growth rate of this market is due to the increasing demand for consumables to ensure hygiene and safety in diagnostic procedures. Based on application, the radiology market will remain the dominant segment of applications in the injector market in the forecast time. This is due to the increasing quantity of radiology procedures utilizing contrast media.

The Hospitals segment is in the leading position for 2020 and is expected to keep the lead in the coming time.

North America accounted for a large portion of the contrast media injectors market in 2020 and is predicted to keep its position throughout the forecast timeframe due to the well-established healthcare infrastructure. Additionally, factors like the increasing demand for more minor invasive procedures and an increase in several chronic diseases because of the altering lifestyles fuel market to grow. It is predicted that the Asia Pacific market, on the other hand, is expected to grow at the highest CAGR over the forecast time due to factors like increased R&D investment, favorable demographics in China and aging populations, and increased cancer rates in Japan. There is a growing interest in the Indian radiology market, as an increased interest from industry players and support from the government to improve healthcare delivery in Asia-Pacific.

The Asia-Pacific region will show the most significant CAGR of 9.6 per cent between 2021 and 2030.

Key Benefits For Stakeholders

  • The report provides a thorough review of the contrast medium injector market, the recent trends, and future estimates to help understand the upcoming investment opportunities.
  • It provides a quantitative analysis of the injectors for the contrast media market between 2021 and 2030 to allow users to profit from the emerging market opportunities.
  • Comprehensive analysis of the injectors that inject contrast media market, based on processes and products helps in understanding the trends within the industry.
  • The key players and their plans are examined for comprehending the market’s competitive landscape for contrast media injectors

Key Market Segments

By Product Type

  • Consumables
    • Syringes
    • Tubes
    • Other Consumables
  • Injector Systems
    • CT Injectors
    • MRI Injectors
    • Angiography Injectors
    • Accessories

By Application

  • Radiology
  • Interventional Cardiology
  • Interventional Radiology

By End-User

  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostics Imaging Centers

Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia & New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Northern Africa
    • Rest of MEA

KEY MARKET PLAYERS

  • Bayer Ag
  • Bracco Imaging S.P.A
  • Guerbet Group
  • Nemours
  • Ulrich GmbH & Co. KG
  • Nemoto Kyorindo Co., Ltd
  • Sino Medical-Device Technology Co., Ltd.
  • APOLLO RT Co. Ltd.
  • Shenzhen Anke High-tech Co. Ltd
  • Shenzen Seacrown Electromechanical Co Ltd.
  • Medtronic AG RT Co. Ltd.

Table of Contents

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies, 2020

3.3.Porters five forces analysis

3.3.1.Top player positioning

3.4.Market dynamics

3.4.1.Drivers, restraints, and opportunity
3.4.2.Drivers

3.4.2.1.Increasing prevalence of cancer and cardiovascular diseases
3.4.2.2.Increase in unhealthy lifestyle

3.4.3.Restraints

3.4.3.1.High cost of contrast media injectors, consumables and accessories

3.4.4.Opportunity

3.4.4.1.Artificial intelligence to provide faster results
3.4.4.2.Increasing demand for MRI scans

3.5.Impact of COVID-19 on Contrast media injectors market

3.5.1.Overview
3.5.2.Impact analysis

CHAPTER 4:CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Consumables

4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by types

4.2.4.1.Syringes market size and forecast
4.2.4.2.Tubes market size and forecast
4.2.4.3.Other consumablesmarket size and forecast

4.3.Injector Systems

4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Injector Systems market size and forecast, by type

4.3.4.1.CT Injectors market size and forecast
4.3.4.2.MRI Injectors market size and forecast
4.3.4.3.Angiography Injectors market size and forecast

4.4.Accessories

4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

CHAPTER 5:CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Radiology

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Interventional Radiology

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Interventional Cardiology

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

CHAPTER 6:CONTRAST MEDIA INJECTORS MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospital

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Diagnostic Imaging Centers

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.Ambulatory surgery centers

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:CONTRAST MEDIA INJECTORS MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key opportunities and forecast
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by product
7.2.4.Market size and forecast, by application
7.2.5.Market size and forecast, by end user

7.2.5.1.U.S.

7.2.5.1.1.U.S. market size and forecast, by product
7.2.5.1.2.U.S. market size and forecast, by application
7.2.5.1.3.U.S. market size and forecast, by end user

7.2.5.2.Canada

7.2.5.2.1.Canada market size and forecast, by Product
7.2.5.2.2.Canada market size and forecast, by application
7.2.5.2.3.Canada market size and forecast, by end user

7.2.5.3.Mexico

7.2.5.3.1.Mexico market size and forecast, by product
7.2.5.3.2.Mexico market size and forecast, by application
7.2.5.3.3.Mexico market size and forecast, by end user

7.3.Europe

7.3.1.Key opportunities and forecast
7.3.2.Market size and forecast, by country
7.3.3.Market size and forecast, by product
7.3.4.Market size and forecast, by application
7.3.5.Market size and forecast, by end user

7.3.5.1.Germany

7.3.5.1.1.Germany market size and forecast, by product
7.3.5.1.2.Germany market size and forecast, by application
7.3.5.1.3.Germany market size and forecast, by end user

7.3.5.2.France

7.3.5.2.1.France market size and forecast, by product
7.3.5.2.2.France market size and forecast, by application
7.3.5.2.3.France market size and forecast, by end user

7.3.5.3.UK

7.3.5.3.1.UK market size and forecast, by product
7.3.5.3.2.UK market size and forecast, by application
7.3.5.3.3.UK market size and forecast, by end user

7.3.5.4.Italy

7.3.5.4.1.Italy market size and forecast, by product
7.3.5.4.2.Italy market size and forecast, by application
7.3.5.4.3.Italy market size and forecast, by end user

7.3.5.5.Spain

7.3.5.5.1.Spain market size and forecast, by Product
7.3.5.5.2.Spain market size and forecast, by application
7.3.5.5.3.Spain market size and forecast, by end user

7.3.5.6.Rest of Europe

7.3.5.6.1.Rest of Europe market size and forecast, by Product
7.3.5.6.2.Rest of Europe market size and forecast, by application
7.3.5.6.3.Rest of Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key opportunities and forecast
7.4.2.Market size and forecast, by country
7.4.3.Market size and forecast, by product
7.4.4.Market size and forecast, by application
7.4.5.Market size and forecast, by end user

7.4.5.1.Japan

7.4.5.1.1.Japan market size and forecast, by Product
7.4.5.1.2.Japan market size and forecast, by application
7.4.5.1.3.Japan market size and forecast, by end user

7.4.5.2.China

7.4.5.2.1.China market size and forecast, by product
7.4.5.2.2.China market size and forecast, by application
7.4.5.2.3.China market size and forecast, by end user

7.4.5.3.Australia

7.4.5.3.1.Australia market size and forecast, by Product
7.4.5.3.2.Australia market size and forecast, by application
7.4.5.3.3.Australia market size and forecast, by end user

7.4.5.4.India

7.4.5.4.1.India market size and forecast, by Product
7.4.5.4.2.India market size and forecast, by application
7.4.5.4.3.India market size and forecast, by end user

7.4.5.5.Rest of Asia-Pacific

7.4.5.5.1.Rest of Asia-Pacific market size and forecast, by Product
7.4.5.5.2.Rest of Asia-Pacific market size and forecast, by application
7.4.5.5.3.Rest of Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key opportunities and forecast
7.5.2.Market size and forecast, by country
7.5.3.Market size and forecast, by product
7.5.4.Market size and forecast, by application
7.5.5.Market size and forecast, by end user

7.5.5.1.Brazil

7.5.5.1.1.Brazil market size and forecast, by Product
7.5.5.1.2.Brazil market size and forecast, by application
7.5.5.1.3.Brazil market size and forecast, by end user

7.5.5.2.Saudi Arabia

7.5.5.2.1.Saudi Arabia market size and forecast, by Product
7.5.5.2.2.Saudi Arabia market size and forecast, by application
7.5.5.2.3.Saudi Arabia market size and forecast, by end user

7.5.5.3.South Africa

7.5.5.3.1.South Africa market size and forecast, by Product
7.5.5.3.2.South Africa market size and forecast, by application
7.5.5.3.3.South Africa market size and forecast, by end user

7.5.5.4.Rest of LAMEA

7.5.5.4.1.Rest of LAMEA market size and forecast, by Product
7.5.5.4.2.Rest of LAMEA market size and forecast, by application
7.5.5.4.3.Rest of LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.APOLLO RT CO. LTD.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Key strategic moves and developments

8.2.BAYER AG

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments

8.3.BRACCO S.P.A.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio

8.4.MEDTRON AG

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Key strategic moves and developments

8.5.NEMOTO KYORINDO CO., LTD.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio

8.6.SHENZHEN ANKE HIGH-TECH CO., LTD.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio

8.7.SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio

8.8.SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Key strategic moves and developments

8.9.THE GUERBET GROUP

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments

8.10.ULRICH GmbH & CO. KG

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL CONTRAST MEDIA INJECTORS MARKET REVENUE, BY PRODUCT, 20202030 ($MILLION)
TABLE 02.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR CONSUMABLES, BY REGION, 20202030($MILLION)
TABLE 03.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR CONSUMABLES, BY APPLICATION, 20202030($MILLION)
TABLE 04.SYRINGES MARKET, 20202030 ($MILLION)
TABLE 05.TUBES MARKET, 20202030 ($MILLION)
TABLE 06.OTHER CONSUMABLES MARKET, 20202030 ($MILLION)
TABLE 07.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR INJECTOR SYSTEMS, BY REGION, 20202028($MILLION)
TABLE 08.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR INJECTOR SYSTEMS, BY APPLICATION, 20202030($MILLION)
TABLE 09.CT INJECTORS MARKET, 20202030 ($MILLION)
TABLE 10.MRI INJECTORS MARKET, 20202030 ($MILLION)
TABLE 11.ANGIOGRAPHY INJECTORS MARKET, 20202030 ($MILLION)
TABLE 12.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR ACCESSORIES, BY REGION, 20202030($MILLION)
TABLE 13.CONTRAST MEDIA INJECTORS MARKET REVENUE, BY APPLICATION, 20202030($MILLION)
TABLE 14.CONTRAST MEDIA INJECTORS MARKET FOR RADIOLOGY REVENUE, BY REGION, 20202030($MILLION)
TABLE 15.INTERVENTIONAL RADIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY REGION, 20202030 ($MILLION)
TABLE 16.INTERVENTIONAL CARDIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY REGION, 20202030 ($MILLION)
TABLE 17.CONTRAST MEDIA INJECTORS MARKET REVENUE, BY END USER, 20202030($MILLION)
TABLE 18.CONTRAST MEDIA INJECTORS MARKET FOR HOSPITAL REVENUE, BY REGION, 20202030($MILLION)
TABLE 19.CONTRAST MEDIA INJECTORS MARKET FOR DIAGNOSTIC IMAGING CENTERS REVENUE, BY REGION, 20202030($MILLION)
TABLE 20.CONTRAST MEDIA INJECTORS MARKET FOR AMBULATORY SURGERY CENTERS REVENUE, BY REGION, 20202030($MILLION)
TABLE 21.CONTRAST MEDIA INJECTORS MARKET, BY REGION, 20202030($MILLION)
TABLE 22.NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 20202030($MILLION)
TABLE 23.NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 24.NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 25.NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 26.U.S. CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 27.U.S. CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 28.U.S. CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 29.CANADA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 30.CANADA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 31.CANADA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 32.MEXICO CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 33.MEXICO CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 34.MEXICO CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 35.EUROPE CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 20202030($MILLION)
TABLE 36.EUROPE CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 37.EUROPE CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 38.EUROPE CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 39.GERMANY CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 40.GERMANY CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 41.GERMANY CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 42.FRANCE CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 43.FRANCE CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 44.FRANCE CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 45.UK CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 46.UK CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 47.UK CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 48.ITALY CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 49.ITALY CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 50.ITALY CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 51.SPAIN CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 52.SPAIN CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 53.SPAIN CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 54.REST OF EUROPE CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 55.REST OF EUROPE CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 56.REST OF EUROPE CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 57.ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 20202030($MILLION)
TABLE 58.ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 59.ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 60.ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 61.JAPAN CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 62.JAPAN CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 63.JAPAN CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 64.CHINA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 65.CHINA. CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 66.CHINA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 67.AUSTRALIA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 68.AUSTRALIA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 69.AUSTRALIA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 70.INDIA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 71.INDIA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 72.INDIA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 73.REST OF ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 74.REST OF ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 75.REST OF ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 76.LAMEA CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 20202030($MILLION)
TABLE 77.LAMEA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 78.LAMEA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 79.LAMEA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 80.BRAZIL CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 81.BRAZIL CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 82.BRAZIL CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 83.SAUDI ARABIA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 84.SAUDI ARABIA. CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 85.SAUDI ARABIA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 86.SOUTH AFRICA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 87.SOUTH AFRICA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 88.SOUTH AFRICA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 20202030($MILLION)
TABLE 89.REST OF LAMEA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 20202030($MILLION)
TABLE 90.REST OF LAMEA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 20202030($MILLION)
TABLE 91.REST OF LAMEA CONTRAST MEDIA INJECTORS MARKET, BY END USER 20202030($MILLION)

LIST OF FIGURES

FIGURE 01.GLOBAL CONTRAST MEDIA INJECTORS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENTS, 20182021*
FIGURE 04.TOP WINNING STRATEGIES, BY YEAR, 20182021*
FIGURE 05.TOP WINNING STRATEGIES: COMPANY , 20182021
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.MODERATE COMPETITIVE RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.DRIVERS, RESTRAINTS, AND OPPORTUNITY
FIGURE 13.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR CONSUMABLES, BY COUNTRY, 20202030(%)
FIGURE 14.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR INJECTOR SYSTEMS, BY COUNTRY, 20202030(%)
FIGURE 15.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR ACCESSORIES, BY COUNTRY, 20202030(%)
FIGURE 16.RADIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 20202030(%)
FIGURE 17.INTERVENTIONAL RADIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 20202030(%)
FIGURE 18.INTERVENTIONAL CARDIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 20202030(%)
FIGURE 19.HOSPITAL FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 20202030(%)
FIGURE 20.DIAGNOSTIC IMAGING CENTERS FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 20202030(%)
FIGURE 21.AMBULATORY SURGERY CENTERS FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 20202030(%)

Major Companies

  • Bayer Ag
  • Bracco Imaging S.P.A
  • Guerbet Group
  • Nemours
  • Ulrich GmbH & Co. KG
  • Nemoto Kyorindo Co., Ltd
  • Sino Medical-Device Technology Co., Ltd.
  • APOLLO RT Co. Ltd.
  • Shenzhen Anke High-tech Co. Ltd
  • Shenzen Seacrown Electromechanical Co Ltd.
  • Medtronic AG RT Co. Ltd.

Major Segmentation

By Product Type

  • Consumables
    • Syringes
    • Tubes
    • Other Consumables
  • Injector Systems
    • CT Injectors
    • MRI Injectors
    • Angiography Injectors
    • Accessories

By Application

  • Radiology
  • Interventional Cardiology
  • Interventional Radiology

By End-User

  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostics Imaging Centers

 

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF